Skin Analytics

Skin Analytics builds AI interventions that enable innovative dermatology pathways to deliver better patient outcomes and sustainability for health systems, globally.

Using the only UKCA Class IIa AI as a Medical Device (AIaMD) for dermatology, we're proud to be working with the NHS to build world leading skin cancer pathways.

Since 2020, Skin Analytics has assessed over 70,000 NHS patients for suspicion of skin cancer, helping Secondary Care organisations remove the need for more than 62% of face-to-face NHS two-week-wait appointments.

Our technology uses AI to assess lesions for skin cancer, allowing NHS organisations and specialists to focus their time on the patients that need them most.

We want to build a future where no one dies from skin cancer.

Across the NHS, AI is expediting the diagnosis and treatment of skin cancer 🏥
@SkinAnalytics tools have already helped identify more than 3,500 skin cancers whilst reducing the number of unnecessary appointments.

🎥 @DHSCgovuk#AISafetySummit pic.twitter.com/v48gv21b3b

— Department for Science, Innovation and Technology (@SciTechgovuk) October 24, 2023